|
ABOUT COMPANY
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company is headquartered in Emeryville, California.
|
EARNINGS
Gross Profit (TTM): 6534000
Market Capitalization: 1687725000
Operating Margin (TTM): 0.18
PE Ratio: None
PEG Ratio: 0
Profit Margin: -0.147
Revenue Per Share (TTM): 2.315
Revenue (TTM): 262722000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 6.98
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.34
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: 51702000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|